SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017527
Filing Date
2019-05-09
Accepted
2019-05-09 06:03:41
Documents
66
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q surf-10q_20190331.htm 10-Q 1560417
2 EX-31.1 surf-ex311_6.htm EX-31.1 17654
3 EX-31.2 surf-ex312_142.htm EX-31.2 17689
4 EX-32.1 surf-ex321_9.htm EX-32.1 7049
5 EX-32.2 surf-ex322_143.htm EX-32.2 7116
  Complete submission text file 0001564590-19-017527.txt   6113770

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT surf-20190331.xml EX-101.INS 1326732
7 XBRL TAXONOMY EXTENSION SCHEMA surf-20190331.xsd EX-101.SCH 42863
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE surf-20190331_cal.xml EX-101.CAL 50430
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE surf-20190331_def.xml EX-101.DEF 154390
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE surf-20190331_lab.xml EX-101.LAB 364671
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE surf-20190331_pre.xml EX-101.PRE 300122
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 19808626
SIC: 2836 Biological Products, (No Diagnostic Substances)